Cell Expansion Market worth USD 26.0 Billion by 2024 | Know Key Trends

1. Cell Expansion Market worth USD 26.0 Billion by 2024 | Know Key Trends The cell expansion market is projected to reach USD 26.0 Billion by 2024 from USD 12.7 Billion in 2019, at a CAGR of 15.4%. The Research report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the Cell Expansion Market, along with revenue estimates & forecasts and market share analysis. Growth in this market is largely driven by the rising global prevalence of cancer, growing awareness regarding cell-based therapies, and increasing government funding cell-based studies. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=194978883

2. Cell Expansion Market segmentation: Based on Product Based on Cell Type Based on Application Based on End Users Based on Regions The Major Players Opearting in the Cell Expansion Market: Key players in the Cell Expansion Market include Thermo Fisher Scientific, Inc. (US), Becton, Dickinson and Company (US), Terumo BCT (Japan), Merck KGaA (Germany), Danaher Corporation (US), Miltenyi Biotec (Germany), Lonza Group Ltd. (Switzerland), STEMCELL Technologies Inc. (Canada), GE Healthcare (US), and Corning, Inc. (US). Thermo Fisher Scientific was the leading player in the global Cell Expansion Market. The company has earned approximately 58% of its total revenue from the US and China together. The company mainly focuses on acquisitions and expansions to strengthen its position in the cell expansion market. In 2018, to expand its bioprocessing product portfolio, the company acquired BD’s bioprocessing unit for USD 477 million. Geographical Detailed Analysis for Cell Expansion Market: North America is the largest regional segment in the Cell Expansion Market. The large share of this segment can primarily be attributed to the rising incidence of cancer, increasing government funding, rising research activates on stem cell therapies, growing awareness regarding advanced treatment methods, growing geriatric population, and the strong presence of industry players in the region. Read More in Detailed (Cell Expansion): https://www.marketsandmarkets.com/PressReleases/cell-expansion.asp

3. About MarketsandMarkets™: MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, and strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. Contact: Mr. Shelly Singh MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: 1-888-600-6441 Email: sales@marketsandmarkets.com